American Journal of Cardiology
Volume 102, Issue 12 , Pages 1602-1607, 15 December 2008

Relation of Epicardial Adipose Tissue to Coronary Atherosclerosis

  • Roxana Djaberi, MD

      Affiliations

    • Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • Joanne D. Schuijf, PhD

      Affiliations

    • Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • Jacob M. van Werkhoven

      Affiliations

    • Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
    • Interuniversity Cardiology Institute of the Netherlands ICIN, Utrecht, The Netherlands
  • ,
  • Gaetano Nucifora, MD

      Affiliations

    • Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • J. Wouter Jukema, MD, PhD

      Affiliations

    • Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
    • Eindhoven Laboratory of Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
    • Interuniversity Cardiology Institute of the Netherlands ICIN, Utrecht, The Netherlands
  • ,
  • Jeroen J. Bax, MD, PhD

      Affiliations

    • Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel: 31-71-526-1757; fax: 31-71-526-6809

Received 3 July 2008; received in revised form 10 August 2008; accepted 10 August 2008. published online 17 October 2008.

Adipose tissue surrounding the coronary arteries has been suggested to induce development of atherosclerosis. We explored the relation between epicardial adipose tissue (EAT) volume and coronary atherosclerosis using multislice computed tomography. The study population consisted of 190 patients who had undergone multislice computed tomographic coronary angiography. Coronary artery calcium score was assessed. In addition, patients were classified as having (1) no atherosclerosis, (2) nonobstructive atherosclerosis (luminal narrowing <50%), (3) obstructive atherosclerosis (luminal narrowing ≥50%) in a single vessel, or (4) obstructive atherosclerosis in the left main coronary artery and/or multiple vessels. Cross-sectional tomographic cardiac slices (3.00-mm thickness, range 35 to 40 slices per heart) were traced semiautomatically from the border of EAT below the apex to a point at the center of the left atrium. Tissue with values from −250 to −30 HU was assigned as EAT. EAT volume within the traced area was then automatically quantified. Mean EAT volume was 84 ± 41 ml. Patients with a coronary artery calcium score >10 had significantly larger average EAT volume (100 ± 40 ml) compared with patients with calcium scores ≤10 (59 ± 27 ml, p <0.001). Sensitivity and specificity for prediction of a calcium score >10 were 77% and 70% with a cut-off EAT value of 73 ml. In patients with normal coronaries mean EAT volume (63 ± 31 ml) was significantly smaller than in patients with atherosclerosis (99 ± 40 ml, p <0.001). Using a cut-off EAT volume of 75 ml, the sensitivity and specificity for presence of atherosclerosis were 72% and 70%. Interestingly, quantity of EAT did not significantly increase with increasing extent or severity of atherosclerosis. After adjustments for risk factors EAT volume remained a significant predictor of coronary atherosclerosis (p = 0.001). In conclusion, a significant relation was shown between EAT volume and presence of coronary atherosclerosis. Quantification of EAT may be useful to identify patients at risk for coronary artery disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Mr. van Werkhoven is financially supported by a research grant from the Netherlands Society of Cardiology (Utrecht, The Netherlands). Dr. Bax received grants from Medtronic (Minneapolis, Minnesota), Boston Scientific (Natick, Massachusetts), BMS Medical Imaging (North Billerica, Massachusetts), St. Jude Medical (St. Paul, Minnesota), GE Healthcare (Buckinghamshire, United Kingdom), and Edwards Lifesciences (Irvine, California).

PII: S0002-9149(08)01382-9

doi:10.1016/j.amjcard.2008.08.010

American Journal of Cardiology
Volume 102, Issue 12 , Pages 1602-1607, 15 December 2008